What causes Turner syndrome?

Turner syndrome is caused by complete or partial loss of one X chromosome in a female. The most common karyotype is 45,X, but mosaicism and structural X abnormalities also produce the phenotype. It is not typically inherited.

How common is Turner syndrome?

Turner syndrome affects approximately 1 in 2,000 female births, with reported incidence ranging from 1 in 4,000 to 1 in 2,500. It is the only viable monosomy syndrome in humans.

How is Turner syndrome diagnosed?

Diagnosis relies on karyotype analysis, typically from peripheral blood. Because mosaicism is common, guidelines recommend examining at least 30 cells, with a second tissue studied when clinical suspicion remains high despite a normal result.

Back to List

Turner Syndrome: Why Short Stature Is Often the First Sign

Q: Why does mosaicism matter clinically?

Mosaicism influences phenotype severity and management. A 45,X/46,XY line signals gonadoblastoma risk and prompts discussion of prophylactic gonadectomy, while other mosaics may present with milder features.

26. 08. 27

Turner syndrome is a chromosomal condition caused by complete or partial monosomy of the X chromosome in a phenotypic female. It is the only viable human monosomy, and its clinical signature spans short stature, ovarian insufficiency, congenital heart disease, and a broad range of endocrine and skeletal findings.

Frequently asked questions

Why does mosaicism matter clinically?

Mosaicism influences both the severity of the phenotype and the direction of management. A 45,X/46,XY cell line signals a risk of gonadoblastoma and prompts discussion of prophylactic gonadectomy, while other mosaic patterns may present with milder features.

Can Turner syndrome be detected prenatally?

Yes. About 25% of cases are identified prenatally or at birth through features such as increased nuchal translucency, cystic hygroma, or fetal lymphedema. Prenatal findings should be confirmed with postnatal karyotyping.

Causes of Turner syndrome

Turner syndrome arises when one X chromosome is entirely or partially missing. Its features stem from reduced dosage of multiple genes on the X chromosome, leading to a broad phenotype that includes short stature, skeletal features, and ovarian dysgenesis. This is also why the extent of chromosomal loss shapes clinical severity. Structural abnormalities such as isochromosome Xq (isoXq) or ring X chromosomes create distinct dosage patterns and outcomes.

Turner syndrome is a chromosomal disorder (45,X) affecting approximately 1 in 2,000 female births and causing multisystem morbidity. Globally, the estimated prevalence in children in 2021 was about 240,598 cases, and it is the only viable monosomy syndrome in humans, with an incidence of roughly 1 in 4,000 to 1 in 2,500 live female births.

Diagnostic testing standards

Karyotype from peripheral blood remains the diagnostic standard, but cell count matters. The American College of Medical Genetics recommends karyotyping a minimum of 30 cells because of the high incidence of mosaicism, and advises studying a second tissue type when suspicion stays high despite a 46,XX result.

When cytogenetics is equivocal or a Y-derived sequence is suspected, FISH and chromosomal microarray add resolution. Prenatal findings on ultrasound or cell-free DNA screening always require postnatal confirmation before a diagnosis is assigned.

A clinician reviews a pediatric growth chart during consultation. Short stature is often the first clue that prompts suspicion of Turner syndrome.

Why timely diagnosis matters

Diagnosis is frequently late. A Danish registry reported a median age at diagnosis of 15.1 years, with mortality increased across all karyotypes and highest among 45,X and isoXq, driven by excess coronary disease, congenital malformations, and endocrine disease.

Early recognition opens the window for growth hormone therapy, timely estrogen replacement, and cardiovascular surveillance for bicuspid aortic valve and aortic dilation. About 25% of patients are identified prenatally or at birth through webbed neck and fetal lymphedema signs.

Consider karyotyping as the first-line test in any female with unexplained short stature, delayed or absent puberty, primary or secondary amenorrhea, or characteristic dysmorphic and cardiac findings. A normal 46,XX result does not exclude low-level mosaicism when the clinical picture fits, so extended cell counts or adjunct methods such as FISH or chromosomal microarray may be warranted. Sequencing tests such as WES or WGS are not first-line for confirming Turner syndrome; they contribute to the workup mainly when the presentation is nonspecific and a monogenic cause is also under consideration.

* This article is educational and does not replace individualized medical advice. Diagnostic and management decisions should be made with a qualified clinician.

Want to learn more about
3billion's genetic testing?

We'll reply within 1 business day.

References

Ding F, Xu J, Xiong J, Li Q, Cheng Z, Deng L. Epidemiological analysis of turner syndrome in children aged 0-14 years: global, regional, and national perspectives (1990-2021). 2025. DOI: 10.3389/fendo.2025.1552300. https://pmc.ncbi.nlm.nih.gov/articles/PMC12074904/
Rasouli M, McDaniel K, Awadalla M, Chung K. Mosaic Turner Syndrome Presenting with a 46,XY Karyotype. 2019. DOI: 10.1155/2019/3719178. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487122/
Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. 2006. DOI: 10.1210/jc.2006-0558. https://pubmed.ncbi.nlm.nih.gov/16849410/

Soo-jung Baek

Marketing Manager

I strive to empower the rare disease community by sharing meaningful insights backed by our company’s expertise.